Loading clinical trials...
Loading clinical trials...
Evaluation of Pharmacokinetics, Safety, Efficacy and Immunogenicity of rAHF-PFM in Previously Treated Hemophilia A Patients - A Continuation Study
Conditions
Interventions
Antihemophilic factor, recombinant, manufactured protein-free
Locations
24
United States
Mountain States Regional Hemophilia and Thrombosis Center
Aurora, Colorado, United States
Childrens Healthcare of Atlanta Blood Bank
Atlanta, Georgia, United States
Comprehensive Bleeding Disorders Center
Peoria, Illinois, United States
Indiana Hemophilia & Thrombosis Center
Indianapolis, Indiana, United States
Michigan State University
East Lansing, Michigan, United States
University of Medicine & Dentistry of New Jersey
New Brunswick, New Jersey, United States
Start Date
November 22, 2001
Primary Completion Date
August 3, 2004
Completion Date
August 3, 2004
Last Updated
August 24, 2021
NCT06820515
NCT07226206
NCT05987449
NCT04563520
NCT04645199
NCT05936580
Lead Sponsor
Baxalta now part of Shire
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions